Professor Onishi of Yamanashi University, co-developing AI software with AiRato, featured as a "Global Pioneer of SBRT" in a world-leading academic journal

Professor Hiroshi Onishi of Yamanashi University, who is co-developing radiation therapy planning support software with AiRato Inc., has been featured as a global pioneer of SBRT in a world-leading academic journal. This is a significant recognition in the advancement of high-precision radiation therapy.
その他NQ 42/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: April 9, 2026 at 21:10
  • 🔍 Collected: April 9, 2026 at 12:30
  • 🤖 AI Analyzed: April 20, 2026 at 09:21 (260h 51m after Collected)
The 'INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS' (Journal of the American Society for Radiation Oncology) is an academic journal followed by radiation oncologists worldwide. This time, in the April 1, 2026 issue, Professor Hiroshi Onishi of Yamanashi University, who is developing radiation therapy planning support software with AiRato Inc., was selected and featured as one of the three global pioneers who built the history of SBRT (Stereotactic Body Radiation Therapy). The published article is attracting attention from experts worldwide as a valuable interview tracing the origins of SBRT, which became the foundation of modern high-precision radiation therapy.

SABR/SBRT Origin Story: An Interview With 3 Pioneers

https://www.sciencedirect.com/science/article/abs/pii/S0360301625063461?dgcid=author

■ About Professor Hiroshi Onishi and AiRato Inc.

Professor Onishi is one of the global pioneers who spearheaded SBRT (Stereotactic Body Radiation Therapy), which enables "pinpoint irradiation" for lung cancer. He is renowned for creating a new standard in radiation therapy that delivers treatment effects comparable to surgery with less burden on the body, by concentrating a large dose on the cancer in a single session.

AiRato began co-development with Professor Onishi in 2023, following its selection for Yamanashi Prefecture's demonstration experiment support project "TRY!YAMANASHI!". AiRato has already completed a Yamanashi University-developed lung cancer model that integrates its accumulated know-how in IMRT AI development with SBRT data. This AI model is incorporated into our radiation therapy planning support software.

Professor Hiroshi Onishi Profile
Professor, Department of Clinical Medicine (Radiation Medicine), Graduate School of Medicine, Yamanashi University
March 1988: Graduated from Chiba University School of Medicine
January 2000: Studied abroad at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center in the USA
January 2014: Professor of Radiology, Yamanashi University School of Medicine, and Director of Radiology, Yamanashi University Hospital

FAQ

What is SBRT?

SBRT (Stereotactic Body Radiation Therapy) is a high-precision radiation therapy that delivers a large dose of radiation to a cancerous area with pinpoint accuracy. It is less burdensome on the body and is expected to have treatment effects comparable to surgery.

What kind of company is Ailat Inc.?

Ailat Inc. is a startup company that develops AI-based software to support radiation therapy planning. In collaboration with Professor Taiyo Nishiyama of Yamanashi University, they contribute to the advancement of high-precision cancer treatment technologies.

What is the significance of the academic journal where Professor Taiyo Nishiyama was featured?

The 'INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS' is the top academic journal in the field of radiation oncology, attracting attention from radiation oncologists worldwide. Being featured in this journal highlights Professor Nishiyama's and the related technology's global authority.

Back to Newsroom (31)